Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04349059 · ClinicalTrials.gov registry record · NA
The Impact of Dietary Pattern on Erectile Function
A NA study of Erectile Dysfunction, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT04349059: Recruiting NA study of Erectile Dysfunction, sponsored by Montefiore Medical Center.
NCT04349059 is a NA study of Erectile Dysfunction that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 46 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04349059, a NA study of Erectile Dysfunction, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether erectile function is impacted by dietary patterns in healthy men with normal erectile function.
Primary Outcome
The first 5 minutes of Rigiscan™ recording is discarded. Erection time is the total time (in minutes) when penile rigidity is ≥ 60% at both the tip and base of the penis with a concurrent increase in penile tumescence at both the tip and base of the penis compared to baseline tumescence as measured by Rigiscan™ during overnight Rigiscan™ use, divided by the total time (in minutes) of overnight Rigiscan™ use. Overnight Rigiscan™ use time is defined as starting 5 minutes after the start of the Rig
Conditions Studied
Interventions
- OTHER Animal based diet
- OTHER Plant based diet
Study Locations (1)
New York
- Montefiore Medical Center, Department of Medicine, Division of Cardiology - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-10-30 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT04349059 shows while recruiting
NCT04349059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Animal based diet is the first listed.
NCT04349059 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04349059 about?
NCT04349059 is a clinical study titled "The Impact of Dietary Pattern on Erectile Function". The goal of this study is to determine whether erectile function is impacted by dietary patterns in healthy men with normal erectile function.
What is the current status of trial NCT04349059?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2023-10-30. Estimated completion is 2026-12.
What conditions does trial NCT04349059 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT04349059?
The interventions under investigation include: Animal based diet (OTHER), Plant based diet (OTHER).
Who is sponsoring clinical trial NCT04349059?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04349059 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04349059's enrollment target sits among peer trials
46 21st of 33 higher than 13 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
-
Penile Lengthening Pre-Penile Prosthesis Implantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI